Evidence map›Paper›PMID 40315012›Full record

ArticleeLife2025

Disruption of the novel nested gene

Shuo He, Lei Huang, Zhuozheng Chen, Ze Yuan, Yue Zhao, Lingfang Zeng, Yi Zhu, Jinlong He

Abstract read
In one paragraph

Article in eLife, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Shuo He *Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics; NHC Key Laboratory of Hormones and Development; Department of Physiology and Pathophysiology, Tianjin Medical University, Tianjin, China.ORCID https://orcid.org/0009-0004-5912-9930
Lei Huang *Department of Heart Center, The Third Central Hospital of Tianjin; Tianjin Universiy Central Hospital; Tianjin Key Laboratory of Extracorporeal Life Support for Critical Diseases; Artificial Cell Engineering Technology Research Center; Tianjin Institute of Hepatobiliary Disease; Nankai University Affinity the Third Central Hospital, Tianjin, China.ORCID https://orcid.org/0000-0002-3911-0915
Zhuozheng ChenProvince and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics; NHC Key Laboratory of Hormones and Development; Department of Physiology and Pathophysiology, Tianjin Medical University, Tianjin, China.
Ze YuanProvince and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics; NHC Key Laboratory of Hormones and Development; Department of Physiology and Pathophysiology, Tianjin Medical University, Tianjin, China.
Yue ZhaoDepartment of Heart Center, The Third Central Hospital of Tianjin; Tianjin Universiy Central Hospital; Tianjin Key Laboratory of Extracorporeal Life Support for Critical Diseases; Artificial Cell Engineering Technology Research Center; Tianjin Institute of Hepatobiliary Disease; Nankai University Affinity the Third Central Hospital, Tianjin, China.ORCID https://orcid.org/0000-0002-6818-2352
Lingfang ZengSchool of Cardiovascular and Metabolic Medicine and Sciences, King's College London British Heart Foundation Centre of Excellence, Faculty of Life Sciences and Medicine, King's College London, London, United Kingdom.ORCID https://orcid.org/0000-0002-0390-4561
Yi ZhuProvince and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics; NHC Key Laboratory of Hormones and Development; Department of Physiology and Pathophysiology, Tianjin Medical University, Tianjin, China.
Jinlong HeProvince and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics; NHC Key Laboratory of Hormones and Development; Department of Physiology and Pathophysiology, Tianjin Medical University, Tianjin, China.ORCID https://orcid.org/0000-0001-7349-8135

Funding

British Heart Foundation FS-15/74/31669Key Research Project in Traditional Chinese Medicine of Tianjin 2023013National Natural Science Foundation of China 32471166National Natural Science Foundation of China 82270516National Natural Science Foundation of China 82330012 and 82127808National Natural Science Foundation of China 82422006Natural Science Foundation of Tianjin Municipality 21JCYBJC01590Natural Science Foundation of Tianjin Municipality 24JCJQJC00060
6 · The paper itself

Abstract

Disturbed shear stress-induced endothelial atherogenic responses are pivotal in the initiation and progression of atherosclerosis, contributing to the uneven distribution of atherosclerotic lesions. This study investigates the role of

Indexed as

AtherosclerosisEndothelial CellsNested GenesStress, MechanicalActive Transport, Cell NucleusAnimalsGene Knockdown TechniquesHumansHuman Umbilical Vein Endothelial CellsInflammationInterferon Regulatory FactorsMiceMice, Inbred C57BLMice, Knockout, ApoEPlaque, AtheroscleroticInterferon Regulatory FactorsIrf5 protein, mouseatherosclerosiscell biologyendothelial cell activationhumanIRF5medicinemousenested geneshear stress

Identifiers

PMID40315012
PMCPMC12048156

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.